Literature DB >> 10022241

Hair testing and doping control in sport.

P Kintz1.   

Abstract

The standard in drug testing for doping control is gas chromatography/mass spectrometry conducted on a urine sample. For the past 20 years, hair analysis has been proposed for identifying drug abusers in forensic science. Specimens can be collected under close supervision without embarrassment and are not subject to evasive maneuvers. In contrast with urine, hair analysis has a wide window of detection, ranging from weeks to months, depending on the length of the hair shaft, and provides information concerning the pattern of an individual's drug abuse. Hair analysis is not yet recognized by the International Olympic Committee, although this technology is accepted in most courts of Justice. In light of potential applications, hair should be included as a suitable specimen to document positive urine cases in doping control.

Mesh:

Year:  1998        PMID: 10022241     DOI: 10.1016/s0378-4274(98)00294-x

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  The possibilities of hair analysis in the determination of involuntary doping in sports.

Authors:  A F Midio; R L de Moraes Moreau; O A Silva
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 2.  Urine nandrolone metabolites: false positive doping test?

Authors:  R M N Kohler; M I Lambert
Journal:  Br J Sports Med       Date:  2002-10       Impact factor: 13.800

Review 3.  Perspectives in the utilisation of Fourier-transform infrared spectroscopy of serum in sports medicine: health monitoring of athletes and prevention of doping.

Authors:  C Petibois; G Déléris; G Cazorla
Journal:  Sports Med       Date:  2000-06       Impact factor: 11.928

4.  Incongruence in doping related attitudes, beliefs and opinions in the context of discordant behavioural data: in which measure do we trust?

Authors:  Andrea Petróczi; Martina Uvacsek; Tamás Nepusz; Nawed Deshmukh; Iltaf Shah; Eugene V Aidman; James Barker; Miklós Tóth; Declan P Naughton
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.